Compare Dr. Reddy's Laboratories Ltd Common Stock (RDY) vs S&P500 ETF (SPY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dr. Reddy's Laboratories Ltd Common Stock vs S&P500 ETF — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.97 (market cap $10.61B), while S&P500 ETF trades at $766.29 (market cap $823.23B). The key difference: S&P500 ETF is far larger — about 77.6× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while S&P500 ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and S&P500 ETF for 206 Days on average.
| RDY | SPY | |
|---|---|---|
Market Cap | $10.61B | $823.23B |
Volume | 3,738,869 | 55,376,546 |
Sector | Health | — |
52-Week High | $15.38 | $779.14 |
52-Week Low | $11.38 | $631.99 |
Typical Hold Time | 0 Days | 206 Days |
Enterprise Value | $10.51B | — |
Dividend Yield | 0.65% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPY (SPDR S&P 500 ETF) trades at $778.05, showing minimal daily movement with a slight decline of 0.02%. Technical indicators signal a bullish trend with moving averages strongly supporting upward momentum, though oscillators remain neutral. The ETF maintains key support at $777 and resistance at $779. Recent news highlights S&P 500 valuation debates and sector rotations, with earnings growth expectations moderating from 35% in 2026 to 15% in 2027 according to Wall Street analysts.
The outlook for SPY remains positive given its broad market exposure and institutional support, though investors face risks from potential market volatility and slowing earnings growth. Current technical strength suggests near-term stability, but macroeconomic factors and sector-specific challenges could impact performance. The ETF's diversification provides resilience, but market-wide valuation concerns warrant cautious optimism.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →About S&P500 ETF
The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on SPY →
